Olga A Maximova

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Cellular inflammatory response to flaviviruses in the central nervous system of a primate host
    Olga A Maximova
    Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892 3203, USA
    J Histochem Cytochem 57:973-89. 2009
  2. ncbi High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence
    Olga A Maximova
    Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20892, USA
    Vaccine 28:8315-26. 2010
  3. ncbi MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype
    Brian L Heiss
    Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
    J Virol 86:5647-59. 2012
  4. ncbi Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype
    Brian L Heiss
    Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Virol 85:1464-72. 2011
  5. ncbi The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome
    Amber R Engel
    Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Virology 405:243-52. 2010
  6. ncbi Visceral and neural larva migrans in rhesus macaques
    Alfonso S Gozalo
    Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
    J Am Assoc Lab Anim Sci 47:64-7. 2008

Collaborators

Detail Information

Publications6

  1. ncbi Cellular inflammatory response to flaviviruses in the central nervous system of a primate host
    Olga A Maximova
    Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892 3203, USA
    J Histochem Cytochem 57:973-89. 2009
    ....
  2. ncbi High-throughput automated image analysis of neuroinflammation and neurodegeneration enables quantitative assessment of virus neurovirulence
    Olga A Maximova
    Laboratory of Infectious Diseases, NIAID, NIH, Bethesda, MD 20892, USA
    Vaccine 28:8315-26. 2010
    ..The implementation of this high-throughput AIA will markedly advance many fields of research including virology, neuroinflammation, neuroscience, and vaccinology...
  3. ncbi MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype
    Brian L Heiss
    Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA
    J Virol 86:5647-59. 2012
    ....
  4. ncbi Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype
    Brian L Heiss
    Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Virol 85:1464-72. 2011
    ..This work suggests that microRNA targeting to control flavivirus tissue tropism and pathogenesis might represent a rational approach for virus attenuation and vaccine development...
  5. ncbi The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome
    Amber R Engel
    Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Virology 405:243-52. 2010
    ..The high level of safety in the central nervous system indicates that vDelta30/E(315)/NS5(654,655) should be further evaluated as a TBEV vaccine...
  6. ncbi Visceral and neural larva migrans in rhesus macaques
    Alfonso S Gozalo
    Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA
    J Am Assoc Lab Anim Sci 47:64-7. 2008
    ..These cases are similar to the low-level or covert cases of Baylisascaris infection described to occur in humans and provide further evidence of the existence of this parasite in the southeastern United States...